Loading
institutionsInstitution
EMBL's European Bioinformatics Institute
Europe's public data institute for molecular biology, running Ensembl, ChEMBL, Europe PMC, the European Genome-phenome Archive and Open Targets.
Also called: EMBL-EBIEuropean Bioinformatics InstituteEuropean Molecular Biology Laboratory
Overview
EMBL-EBI is the bioinformatics site of the European Molecular Biology Laboratory (founded 1974; the EBI opened in Hinxton in 1994). It maintains open resources that cancer research runs on: Ensembl genome annotation, UniProt (with SIB and PIR), ChEMBL drug and bioactivity data, the PDBe structure archive, Expression Atlas, Europe PMC literature, the European Genome-phenome Archive for controlled-access patient genomes, and the AlphaFold Protein Structure Database built with Google DeepMind. It is a founding partner of Open Targets with the Sanger Institute and pharmaceutical companies, and trains thousands of scientists a year. EMBL's Heidelberg and other sites contribute structural, cell and imaging biology.
Location
Hinxton, GB
Type
research institute
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#223 · 26 points (0 Newsweek + 0 NCI + 26 from 13 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-01.
Matched to European Bioinformatics Institute, including child institutions. 58 works · 841 citations · 66% open access · 2% clinical trials · 2% reviews.
Oncology works per year
152022
122023
42024
212025
62026
Most works
- Neil David Rawlings17 works
- Luigi Nezi10 works
- Danilo Cagnina10 works
- Tiziano Dallavilla10 works
- Carlotta Catozzi10 works
- Nicola Fazio10 works
- Georg Zeller10 works
- Martin H. Schaefer10 works
- Jakob Wirbel10 works
- Simona Paola Ravenda10 works
Most cited
- Ensembl
- ChEMBL
- Europe PMC
- European Genome-phenome Archive
- Open Targets
- AlphaFold DB
Ewan Birney
Director of EMBL-EBI
GenomicsBioinformaticsFunctional genomics
Computational biologist who directs EMBL-EBI, home of the open genomic and cancer data resources used worldwide.
Julio Saez-Rodriguez
Head of Research
Computational biologySystems biologyDrug response modelling
Systems biologist heading research at EMBL-EBI, known for computational methods to model signalling networks and predict cancer drug response.
Similar pages
- CollectionTherapeutic Target Database (TTD)
Shares DrugBank & ChEMBL, Open Targets Platform.
- CompanyBostonGene
Shares RNA sequencing & expression profiling, Data silos, Whole-exome & whole-genome sequencing.
- IdeaAI-designed proteins that grip the floppy parts of cancer drivers
- IdeaRequire every oncology candidate to publish how much reaches the brain
Shares DrugBank & ChEMBL, Knowledge reaches practice too slowly.
- IdeaPre-registered, publicly scored AI ranking of repurposing candidates for cancer
Shares DrugBank & ChEMBL, Open Targets Platform.
- IdeaA global rapid tissue donation network for metastatic disease
Shares Proteomics & phosphoproteomics, Data silos, Whole-exome & whole-genome sequencing.
- TechnologyAlphaFold 3
- PersonLi Ding
Shares Proteomics & phosphoproteomics, Whole-exome & whole-genome sequencing.
fronts
technologies
companies
institutions
collections
people
bottlenecks
Open-source projects
All open source in oncology →Open-source projects that this organisation maintains, from OnCo's own catalogue: licence and last activity as the repository reported them on the day of the fetch. Listing is not endorsement; check the licence before reuse and the validation before clinical use.
The Ensembl Variant Effect Predictor annotates variants with genes, consequences and population and clinical data; the annotation step in most somatic pipelines.
Structural variant discovery from paired-end and split reads, with a somatic filtering mode.
The official Python client for ChEMBL, EMBL-EBI's open database of bioactive molecules and their assay data.
The standardisation and validation rules ChEMBL applies to chemical structures, released for anyone to reuse.
The React front end of the Open Targets Platform.
EMBL-EBI's application ontology that Open Targets and the GWAS Catalog use for diseases and traits.
The EMBL-EBI, Sanger and pharma partnership's open platform for target identification and prioritisation, with open data downloads and APIs.